Critically important need for these expanding patient populations. Kudos to the team led by @fredhutch ID Team, and thanks for the opportunity to participate! #immunocompromised #bonemarrowtransplant #cellandgenetherapy #infection

Resharing now that the full article is out! Updated NMDP/CIBMTR guidelines on donor selection for allo-HCT. Grateful to have contributed to this effort 🧵 https://t.co/b1RyyLQf6u

Just Published in @ASTCT_Journal: Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. Read more:

🗓️ ONE month left! Early-career physician‑scientists working to prevent/treat post‑transplant or cell therapy complications, don't forget to apply for the 2026 Amy Strelzer Manasevit Research Program‼️ 🔬 Up to $400K over 5 years 📅 Due: Aug 7, 2025 🔗 https://t.co/9NU6VkwHmg

🚨 Cutting-Edge Science in Stem Cell Transplants & Cellular Therapies! 🚨 Join @JeffAuletta , MD, as he dives deep into the science behind stem cell transplants and cellular therapies, including CAR T-cell therapy and hematopoietic cell transplantation (HCT)! 🧬✨

New CIBMTR Scientific Director: Najla El Jurdi, MD, to serve as Scientific Director of Graft-versus-Host Disease Working Committee. Read more about this exciting announcement: https://t.co/k8paTmbigl

NEW study results just published in @JCO_ASCO: Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation. Read more:

Proud to share @JCO_ASCO paper of the ACCESS study run by @CIBMTR and sponsored by @nmdp_org 145 recipients of MMUD grafts using PTCy experienced outcomes similar to matched transplants, including <7/8 grafts. 59% of patients were diverse!

Announcing the first EVER @JCO_ASCO Art of Oncology Narrative Medicine Contest! 🎉✍️🎗️🩺🎉 We're looking for essays that explore the human experience of cancer and reflect on the experience of trainees and early career hematologists/oncologists. Apply Now!

The @nmdp_org Amy Strelzer Manasevit Research Program is more than funding - it's a long-term investment in the people driving innovation in post-transplant care. If you're at the start of your research career, I encourage you to apply. @ASTCT @CIBMTR https://t.co/Wh5WEkgrb1

We released a 2 part update w/ our guest @JeffAuletta from @nmdp_org & @CIBMTR on SCT 🩸 (from our initial ep 9/25/23) 🧬 part 1: what is SCT, types & risks of SCT, how to find a donor, barriers/inequities 🧬 part 2: conditioning regimens, GvHD, toxicities & career path

ICYMI: Our Senior VP of Health Equity, Dr. @JeffAuletta spoke with @TargetedOnc about the latest in blood stem cell transplant and CAR T-cell therapies, highlighting the need for systemic changes to improve access. Hear his insights 👇

WATCH: Jeff Auletta, MD, (@JeffAuletta) discusses his key takeaways from the 2025 Transplant and Cellular Therapy Meetings. #Tandem25 #BMSCT | @nmdp_org https://t.co/iZKRqt1m8B

Tune in to hear @DrMonzrAlMalki of @cityofhope and @JeffAuletta of @NMDP_org discuss evaluating PTCy-based GVHD prophylaxis in hematologic malignancies. Watch here:

Congratulations, Dr. Zeiser as the @ASTCT E. Donnall Thomas Lecture recipient! Well deserved! 2025 @ASTCT @CIBMTR Tandem Meetings #Tandem25

Congratulations, Dr. Antin as @ASTCT Lifetime Achievement Award! Well deserved! 2025 @ASTCT @CIBMTR Tandem Meetings #Tandem25

Congrats, Dr. Giralt as the 2025 @CIBMTR Mortimer M. Bortin Lecture! @ASTCT @CIBMTR Tandem Meetings #Tandem25

Congrats, Dr. Barroso Duarte as the 2025 @CIBMTR Distinguished Service Award! Well deserved! @ASTCT @CIBMTR Tandem Meetings #Tandem25

Great to see next gen thrive by making an impact! Kudos to Drs. Maria Pereda Ginnochio @marialepg17 and Manuel Espinoza-Gutarra, 2 members of @ASTCT @nmdp_org ACCESS Initiative Faculty Immersion Program led by Drs. @AGomez_MD Anu Hall!

Great session at @ASTCT @nmdp_org ACCESS Initiative Symposium at the 2025 @ASTCT @CIBMTR Tandem Meetings! Junior Faculty Immersion Program, Caregiver Reimaged, and Health Equity in Practice Toolkit. #Tandem25